GL1X · GenesisL1 explorer

MolNFT v1 · #16741 · protein

Tryparedoxin II from C.FASCICULATA solved by sulphur phasing

1O81: “Tryparedoxin II from C.FASCICULATA solved by sulphur phasing”. X-ray diffraction, 1 ligand (SO4), 4 pockets (best druggability 0.37). MolNFT v1 #16741 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
1O81
Type
protein
Length
296 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tryparedoxin II
UniProt
O77093
Ligands
SO4
Pockets
4 · best druggability 0.37

Structure

x-ray diffraction · 2 distinct chains · 33% helix, 22% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATryparedoxin IIprotein15235% helix, 21% strandO77093
BTryparedoxin IIprotein14432% helix, 24% strandO77093

Ligands and binding sites

  • SO4 · Sulfate ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1820.370.7619empty
2730.320.7414empty
3660.320.7518SO4
4740.270.7217empty

Interfaces

1 interface between chains.

  • A–B · 664 Ų buried · 10 hydrogen bonds · protein-protein

Compared structures

  • 1O81 · Tryparedoxin II from C.fasciculata solved by sulphur phasing · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.